Ocular Therapeutix, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-31.8% -$11M
$-45M
Free Cash Flow↓-1305.4% -$3M
$-3M
Investing Cash Flow↓-658.0% -$2M
$-2M
Financing Cash Flow↑+9857.4% +$445M
$449M
Capex↑+1305.4% +$3M
$3M
Stock-Based Comp↑+57.8% +$4M
$11M
Debt Repaid
—
D&A↑+31.1% +$296K
$1M
SBC Allocated Expense↑+57.8% +$4M
$11M
SBC Unrecognized Cost
$9M